During the past decade, Onassis Cardiac Surgery Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onassis Cardiac Surgery Center" #1 sponsor was "Aretaieion University Hospital" with 4 trials, followed by "Medtronic Cardiac Surgery" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "AHEPA University Hospital" with 1 trials sponsored and "Abbott Medical Devices" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onassis Cardiac Surgery Center" #1 collaborator was "Onassis Cardiac Surgery Centre" with 2 trials as a collaborator, "Advance Research Associates" with 1 trials as a collaborator, "Attikon Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "CDI Centro Diagnostico Italiano" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Onassis Cardiac Surgery Center" are "Hypertension, Pulmonary" (4 trials), "Cardiac Failure" (3 trials), "Cardiovascular Diseases" (3 trials), "Cardiac Disease" (2 trials) and "Connective Tissue Diseases" (2 trials). Many other conditions were trialed in "Onassis Cardiac Surgery Center" in a lesser frequency.

Most popular intervention types in "Onassis Cardiac Surgery Center" are "Device" (11 trials), "Drug" (6 trials), "Procedure" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ralinepag" (2 trials), "levosimendan at a dose of 6 mcg/kg" (2 trials), "CABG and SAVR" (1 trials) and "CAVGJ" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onassis Cardiac Surgery Center" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Onassis Cardiac Surgery Center". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Onassis Cardiac Surgery Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onassis Cardiac Surgery Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".